IL6 and diabetes mellitus: While markers of inflammation such as IL-6 and CRP were elevated across all patients and there was no difference in the prevalence of diabetes between POD cases and controls, only those who developed POD exhibited a distinct and exaggerated metabo-inflammatory profile on postoperative day one.